Seborrheic dermatitis: a newly reported side effect of neuroleptics.
Of 42 chronic patients with neuroleptic-induced parkinsonism, 25 were found to have seborrheic dermatitis; this side effect was seen in only 1 of 17 acute patients with neuroleptic-induced parkinsonism. Parkinsonian symptoms may precede the onset of seborrheic dermatitis in patients receiving chronic neuroleptic treatment.
D000328:Adult; D000368:Aged; D014150:Antipsychotic Agents / Q000009:adverse effects*; D002908:Chronic Disease; D012628:Dermatitis, Seborrheic / Q000209:etiology*; D005260:Female; D006760:Hospitalization; D006801:Humans; D008297:Male; D001523:Mental Disorders / Q000188:drug therapy; D008875:Middle Aged; D010302:Parkinson Disease, Secondary / Q000139:chemically induced*; D011446:Prospective Studies
D014150:Antipsychotic Agents